4,254 followers
RT @MSJ_Research: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS https://t.co/O…
RT @MSJ_Research: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS https://t.co/O…
RT @DraganaObrado20: #Tysabri vs #Gylenia in active RRMS BEST-MS & REVEAL TRIAL 👉Tysabri superior to Gylenia, 12 months follow-up: NEDA…
Felicitations à Cohen et tous les participants de cette étude! https://t.co/ABwjqzxycW
RT @MSJ_Research: BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS https://t.co/O…